Table 1. Clinical characteristics, positive sites, and resistance profile of the strains isolated from patients colonized by S. aureus.
Case/age in years | Malignancy | Recent hospitalization | Antibiotic prophylaxis | Positive sites | Strain profile | Long permanency device | Blood culture S. aureus | Days of hospitalization | Number of episodes during study |
---|---|---|---|---|---|---|---|---|---|
A/10 | ALL | Yes | Yes | Nasal | MSSA | No | Negative | 7 | 2 |
B/4 | Wilms | No | Yes | Nasal | MSSA | No | Positive/ MSSA | 8 | 1 |
C/4 | Histiocytosis | Yes | No | Nasal OP Anal |
HA-MRSA | No Yes |
Negative | 16 | 1 |
D/15 | Ewing | Yes | No | Anal Nasal |
HA-MRSA | (180 days) | Negative | 22 | 1 |
E/4 | Neuroblastoma | Yes | No | Anal OP |
CA-MRSA | No | Negative | 10 | 2 |
ALL – acute lymphocytic leukemia; HA-MRSA – health-care associated methicillin-resistant Staphylococcus aureus; CA-MRSA – community-associated methicillin-resistant Staphylococcus aureus; OP – oropharyngeal